Abstract
The initiation of human cancer is primarily driven by carcinogenic substances including chemicals, radiations, viruses, and parasites. The carcinogenesis mechanism is a complex process in which cellular DNA mutations contribute to the initiation, which is the first step, and seems to be irreversible. The second stage is promoted over a long period and is largely reversible in initial stages. The key events for the carcinogenesis process tend to be epigenetic. Cancer genes are classified by their ability to regulate oncogenesis as the dominant oncogenes and recessive tumor suppressors. Activation of oncogenes may be due to the occurrence of mutations in these genes. Besides, a single sufficiently activated oncogene will initiate the entire process of the cancerous transition of a normal cell. Their function in cancer growth has been widely demonstrated in experimental studies involving viruses and chromosome translocations. Furthermore, micro-RNAs (miRNAs) are preserved throughout development and regulate gene expression during cell proliferation, growth, and even in cancer progression by an unidentified control mechanism. miRNAsĀ also play a crucial function in malignancy. The discovery and elucidation of the carcinogenic molecular pathways of carcinogens provide a deeper understanding of how genetic manipulation influences the mechanism of neoplastic development. The current chapter explains the different mechanisms involved in the carcinogenesis process.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abate-Shen C (2000) Molecular genetics of prostate cancer. Genes Dev 14:2410ā2434. https://doi.org/10.1101/gad.819500
Abel EL, DiGiovanni J (2011) Multistage carcinogenesis. Curr Cancer Res 6:27ā51. https://doi.org/10.1007/978-1-61737-995-6_2
Abel EL, Angel JM, Kiguchi K, DiGiovanni J (2009) Multi-stage chemical carcinogenesis in mouse skin: fundamentals and applications. Nat Protoc 4:1350ā1362. https://doi.org/10.1038/nprot.2009.120
Ahmad J, Hasnain SE, Siddiqui MA et al (2013) MicroRNA in carcinogenesis & cancer diagnostics: a new paradigm. Indian J Med Res 37(4):680ā694
Alnuaimi AD, Wiesenfeld D, OāBrien-Simpson NM et al (2015) Oral Candida colonization in oral cancer patients and its relationship with traditional risk factors of oral cancer: a matched case-control study. Oral Oncol 51(2):139ā145. https://doi.org/10.1016/j.oraloncology.2014.11.008
Aykut B, Pushalkar S, Chen R et al (2019) The fungal mycobiome promotes pancreatic oncogenesis via activation of MBL. Nature 574:264ā267. https://doi.org/10.1038/s41586-019-1608-2
Baca SC, Prandi D, Lawrence MS et al (2013) Punctuated evolution of prostate cancer genomes. Cell 153:666ā677. https://doi.org/10.1016/j.cell.2013.03.021
Baldus SE, Schaefer K-L, Engers R et al (2010) Prevalence and heterogeneity of KRAS, BRAF, and PIK3CA mutations in primary colorectal adenocarcinomas and their corresponding metastases. Clin Cancer Res 16:790ā799. https://doi.org/10.1158/1078-0432.CCR-09-2446
Bandres E, Agirre X, Bitarte N et al (2009) Epigenetic regulation of microRNA expression in colorectal cancer. Int J Cancer 125:2737ā2743. https://doi.org/10.1002/ijc.24638
Banu A, Lax AJ, Grigoriadis AE (2020) In vivo targets of Pasteurella Multocida toxin. Int J Mol Sci 21:2739. https://doi.org/10.3390/ijms21082739
Barrett JC (1993) Mechanisms of multistep carcinogenesis and carcinogen risk assessment. Environ Health Perspect 100:9ā20. https://doi.org/10.1289/ehp.931009
Belhassen H, JimĆ©nez-DĆaz I, Arrebola JP et al (2015) Zearalenone and its metabolites in urine and breast cancer risk: a case-control study in Tunisia. Chemosphere 128:1ā6. https://doi.org/10.1016/j.chemosphere.2014.12.055
Berenblum I, Shubik P (1949) An experimental study of the initiating stage of carcinogenesis, and a re-examination of the somatic cell mutation theory of cancer. Br J Cancer 3:109ā118. https://doi.org/10.1038/bjc.1949.13
Boquet P (1999) Bacterial toxins inhibiting or activating small GTP-binding proteins. Ann N Y Acad Sci 886:83ā90. https://doi.org/10.1111/j.1749-6632.1999.tb09403.x
Botezatu A, Iancu IV, Popa O et al (2016) Mechanisms of oncogene activation. In: Bulgin D (ed) New aspects in molecular and cellular mechanisms of human carcinogenesis. IntechOpen, Croatia
Braoudaki M, Tzortzatou-Stathopoulou F (2011) Tumorigenesis related to retroviral infections. J Infect Dev Ctries 5:751ā758. https://doi.org/10.3855/jidc.1773
Bray F, Ferlay J, Soerjomataram I et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394ā424. https://doi.org/10.3322/caac.21492
Brennan B (2006) Nasopharyngeal carcinoma. Orphanet J Rare Dis 1:23
Bushati N, Cohen SM (2007) microRNA functions. Annu Rev Cell Dev Biol 23:175ā205. https://doi.org/10.1146/annurev.cellbio.23.090506.123406
Calin GA, Sevignani C, Dumitru CD et al (2004) Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A 101(9):2999ā3004. https://doi.org/10.1073/pnas.0307323101
Caputo R, Tuccillo C, Manzo BA et al (2003) Helicobacter pylori VacA toxin up-regulates vascular endothelial growth factor expression in MKN 28 gastric cells through an epidermal growth factor receptor-, cyclooxygenase-2-dependent mechanism. Clin Cancer Res 9:2015ā2021
Chang Y-T, Chang M-C, Huang K-W et al (2014) Clinicopathological and prognostic significances of EGFR, KRAS and BRAF mutations in biliary tract carcinomas in Taiwan. J Gastroenterol Hepatol 29:1119ā1125. https://doi.org/10.1111/jgh.12505
Cicenas J, Tamosaitis L, Kvederaviciute K et al (2017) KRAS, NRAS and BRAF mutations in colorectal cancer and melanoma. Med Oncol 34:26. https://doi.org/10.1007/s12032-016-0879-9
Clevenger CV, Furth PA, Hankinson SE, Schuler LA (2003) The role of prolactin in mammary carcinoma. Endocr Rev 24:1ā27. https://doi.org/10.1210/er.2001-0036
Cohen SM, Arnold LL (2011) Chemical carcinogenesis. Toxicol Sci 120:S76āS92. https://doi.org/10.1093/toxsci/kfq365
Conti CJ (2010) Mechanisms of tumor progression. In: Comprehensive toxicology. Elsevier, pp 335ā347
Coyle YM, Xie XJ, Lewis CM et al (2007) Role of physical activity in modulating breast cancer risk as defined by APC and RASSF1A promoter hypermethylation in nonmalignant breast tissue. Cancer Epidemiol Biomark Prev 16(2):192
Croce CM (2008) Oncogenes and cancer. N Engl J Med 358(5):502ā511
de Gerlache J, Taper HS, Lans M et al (1987) Dietary modulation of rat liver carcinogenesis. Carcinogenesis 8:337ā340. https://doi.org/10.1093/carcin/8.2.337
Derelanko MJ (2001) Carcinogenesis. In: Handbook of toxicology, 2nd edn. CRC Press, Boca Raton
El Adlouni C, Tozlovanu M, Naman F et al (2006) Preliminary data on the presence of mycotoxins (ochratoxin A, citrinin and aflatoxin B1) in black table olives āGreek styleā of Moroccan origin. Mol Nutr Food Res 50:507ā512. https://doi.org/10.1002/mnfr.200600055
Elder DE (2016) Melanoma progression. Pathology 48:147ā154. https://doi.org/10.1016/j.pathol.2015.12.002
El-Serag HB (2012) Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 142(6):1264ā1273.e1. https://doi.org/10.1053/j.gastro.2011.12.061
Eser S, Schnieke A, Schneider G, Saur D (2014) Oncogenic KRAS signalling in pancreatic cancer. Br J Cancer 111:817ā822. https://doi.org/10.1038/bjc.2014.215
Esquela-Kerscher A, Slack FJ (2006) Oncomirs ā microRNAs with a role in cancer. Nat Rev Cancer 6:259ā269. https://doi.org/10.1038/nrc1840
FaĆÆs T, Delmas J, Serres A et al (2016) Impact of CDT toxin on human diseases. Toxins (Basel) 8(7):220
Fearon ER (2011) Molecular genetics of colorectal cancer. Annu Rev Pathol 6:479ā507. https://doi.org/10.1146/annurev-pathol-011110-130235
Foss FM, Zinzani PL, Vose JM et al (2011) Peripheral T-cell lymphoma. Blood 117(25):6756ā6767
Frenkel K, Wei H, Bhimani R et al (1993) Inhibition of tumor promoter-mediated processes in mouse skin and bovine lens by caffeic acid phenethyl ester. Cancer Res 53:1255ā1261
Gariglio P (2012) Oncogenes and tumor suppressor genes. In: Gariglio P (ed) Molecular oncology: principles and recent advances. Bentham Science Publishers, pp 64ā82
Gelderblom WCA, Abel S, Smuts CM et al (2001) Fumonisin-induced hepatocarcinogenesis: mechanisms related to cancer initiation and promotion. Environ Health Perspect 109:291ā300. https://doi.org/10.1289/ehp.01109s2291
Gourama H, Bullerman LB (1995) Aspergillus flavus and aspergillus parasiticus: Aflatoxigenic fungi of concern in foods and feedsā : a review. J Food Prot 58(12):1395ā1404
Grizzi F, Di Ieva A, Russo C et al (2006) Cancer initiation and progression: an unsimplifiable complexity. Theor Biol Med Model 3:37
Hacein-Bey-Abina S, Garrigue A, Wang GP et al (2008) Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. J Clin Invest 118(9):3132ā3142. https://doi.org/10.1172/JCI35700
Hanahan D, Robert AW (2017) Biological hallmarks of cancer. Holland-Frei Cancer Med 1ā10. https://doi.org/10.1002/9781119000822.hfcm002
Harris CC (1991) Molecular basis of multistage carcinogenesis. Princess Takamatsu Symp 22:3ā19
Harris H, Miller OJ, Klein G et al (1969) Suppression of malignancy by cell fusion. Nature 223:363ā368. https://doi.org/10.1038/223363a0
Hart RW, Turturro A (1988) Current views of the biology of cancer. In: Carcinogen risk assessment. Springer US, Boston, MA, pp 19ā33
Hartl M, Bister K (2013) Oncogenes. In: Brennerās encyclopedia of genetics, 2nd edn. Academic Press, San Diego
Hecker E (1978) Co-carcinogens or modulators of carcinogenesis. New aspects of the etiology of human tumors and of the molecular mechanisms of carcinogenesis. Naturwissenschaften 65:640ā648. https://doi.org/10.1007/BF00401906
Herrera LA, BenĆtez-Bribiesca L, Mohar A, Ostrosky-Wegman P (2005) Role of infectious diseases in human carcinogenesis. Environ Mol Mutagen 45:284ā303
Hou W, Liu J, Chen P et al (2014) Mutation analysis of key genes in RAS/RAF and PI3K/PTEN pathways in Chinese patients with hepatocellular carcinoma. Oncol Lett 8:1249ā1254. https://doi.org/10.3892/ol.2014.2253
Hristova M, Birse D, Hong Y, Ambros V (2005) The Caenorhabditis elegans Heterochronic regulator LIN-14 is a novel transcription factor that controls the developmental timing of transcription from the insulin/insulin-like growth factor gene ins-33 by direct DNA binding. Mol Cell Biol 25:11059ā11072. https://doi.org/10.1128/mcb.25.24.11059-11072.2005
Ishii A, Matsuoka H, Aji T et al (1994) Parasite infection and cancer: with special emphasis on Schistosoma japonicum infections (Trematoda). A review. Mutat Res Mol Mech Mutagen 305:273ā281. https://doi.org/10.1016/0027-5107(94)90247-X
JanÄĆk S, DrĆ”bek J, Radzioch D, HajdĆŗch M (2010) Clinical relevance of KRAS in human cancers. J Biomed Biotechnol 2010:1ā13. https://doi.org/10.1155/2010/150960
Janku F, Lee JJ, Tsimberidou AM et al (2011) PIK3CA mutations frequently coexist with ras and braf mutations in patients with advanced cancers. PLoS One 6(7):e22769. https://doi.org/10.1371/journal.pone.0022769
Jones PA (2003) Epigenetics in carcinogenesis and cancer prevention. Ann N Y Acad Sci 983:213ā219
Jones PA, Baylin SB (2007) The epigenomics of cancer. Cell 128(4):683ā692
Jones PA, Takai D (2001) The role of DNA methylation in mammalian epigenetics. Science 293:1068ā1070
Kamisawa T, Wood LD, Itoi T, Takaori K (2016) Pancreatic cancer. Lancet 388:73ā85. https://doi.org/10.1016/S0140-6736(16)00141-0
Kanwal R, Gupta S (2012) Epigenetic modifications in cancer. Clin Genet 81(4):303ā311
Karachaliou N, Mayo C, Costa C et al (2013) KRAS mutations in lung cancer. Clin Lung Cancer 14:205ā214. https://doi.org/10.1016/j.cllc.2012.09.007
Karin M, Greten FR (2005) NF-ĪŗB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 5:749ā759. https://doi.org/10.1038/nri1703
Kempf VAJ, Volkmann B, Schaller M et al (2001) Evidence of a leading role for VEGF in Bartonella henselae -induced endothelial cell proliferations. Cell Microbiol 3:623ā632. https://doi.org/10.1046/j.1462-5822.2001.00144.x
Kew MC (2013) Aflatoxins as a cause of hepatocellular carcinoma. J Gastrointest Liver Dis 22:305ā310
Kim YI, Yu ES, Kim ST (1989) Intraductal variant of peripheral cholangiocarcinoma of the liver with Clonorchis sinensis infection. Cancer 63:1562ā1566. https://doi.org/10.1002/1097-0142(19890415)63:8<1562::aid-cncr2820630819>3.0.co;2-8
Klose RJ, Bird AP (2006) Genomic DNA methylation: the mark and its mediators. Trends Biochem Sci 31:89ā97. https://doi.org/10.1016/j.tibs.2005.12.008
KnasmĆ¼ller S, Cavin C, Chakraborty A et al (2004) Structurally related mycotoxins ochratoxin a, ochratoxin B, and citrinin differ in their genotoxic activities and in their mode of action in human-derived liver (HepG2) cells: implications for risk assessment. Nutr Cancer 50(2):190ā197. https://doi.org/10.1207/s15327914nc5002_9
Kwon O, Soung NK, Thimmegowda NR et al (2012) Patulin induces colorectal cancer cells apoptosis through EGR-1 dependent ATF3 up-regulation. Cell Signal 24:943ā950. https://doi.org/10.1016/j.cellsig.2011.12.017
Lax AJ, Thomas W (2002) How bacteria could cause cancer: one step at a time. Trends Microbiol 10:293ā299. https://doi.org/10.1016/S0966-842X(02)02360-0
Lee YS, Kim HK, Chung S et al (2005) Depletion of human micro-RNA miR-125b reveals that it is critical for the proliferation of differentiated cells but not for the down-regulation of putative targets during differentiation. J Biol Chem 280(17):16635ā16641. https://doi.org/10.1074/jbc.M412247200
Leiderman YI, Kiss S, Mukai S (2007) Molecular genetics of RB1āthe retinoblastoma gene. Semin Ophthalmol 22:247ā254. https://doi.org/10.1080/08820530701745165
Lewis JG, Adams DO (1987) Inflammation, oxidative DNA damage, and carcinogenesis. Environ Health Perspect 76:19ā27. https://doi.org/10.1289/ehp.877619
Lim JH (2011) Liver flukes: the malady neglected. Korean J Radiol 12:269. https://doi.org/10.3348/kjr.2011.12.3.269
Liu X, Chen X, Yu X et al (2013) Regulation of microRNAs by epigenetics and their interplay involved in cancer. J Exp Clin Cancer Res 32:96. https://doi.org/10.1186/1756-9966-32-96
Loeb LA, Harris CC (2008) Advances in chemical carcinogenesis: a historical review and prospective. Cancer Res 68(17):6863ā6872
Ma Y-Y, Wei S-J, Lin Y-C et al (2000) PIK3CA as an oncogene in cervical cancer. Oncogene 19:2739ā2744. https://doi.org/10.1038/sj.onc.1203597
Ma C, Wickham ME, Guttman JA et al (2006) Citrobacter rodentium infection causes both mitochondrial dysfunction and intestinal epithelial barrier disruption in vivo: role of mitochondrial associated protein (Map). Cell Microbiol 8:1669ā1686. https://doi.org/10.1111/j.1462-5822.2006.00741.x
Martin OCB, Frisan T (2020) Bacterial genotoxin-induced DNA damage and modulation of the host immune microenvironment. Toxins (Basel) 12:63. https://doi.org/10.3390/toxins12020063
Martin JL, Maldonado JO, Mueller JD et al (2016) Molecular studies of HTLV-1 replication: an update. Viruses 8(2):1ā22
Matsuda NM, Miller SM, Evora PRB (2009) The chronic gastrointestinal manifestations of Chagas disease. Clinics (Sao Paulo) 64:1219ā1224. https://doi.org/10.1590/S1807-59322009001200013
Mendelsohn J, Howley PM, Israel MA et al (2008) The molecular basis of cancer. Elsevier, Philadelphia, PA
Mitreva M (2012) The genome of a blood fluke associated with human cancer. Nat Genet 44:116ā118. https://doi.org/10.1038/ng.1082
Moutinho C, Esteller M (2017) MicroRNAs and epigenetics. Adv Cancer Res 135:189ā220
Murphy AE, Charnay-Sonnek F (2019) Basis of carcinogenesis. Springer, Dordrecht, pp 1ā17
Nath G, Gulati AK, Shukla VK (2010) Role of bacteria in carcinogenesis, with special reference to carcinoma of the gallbladder. World J Gastroenterol 16(43):5395ā5404. https://doi.org/10.3748/wjg.v16.i43.5395
Oliveira PA, ColaƧo A, Chaves R et al (2007) Chemical carcinogenesis. An Acad Bras Cienc 79:593ā616. https://doi.org/10.1590/S0001-37652007000400004
Olson RE (1992) Vitamins and carcinogenesis: an overview. J Nutr Sci Vitaminol (Tokyo) Spec No:313ā316. https://doi.org/10.3177/jnsv.38.special_313
Orem J, Mbidde EK, Lambert B et al (2007) Burkittās lymphoma in Africa, a review of the epidemiology and etiology. Afr Health Sci 7:166ā175. https://doi.org/10.5555/afhs.2007.7.3.166
Ostry V, Malir F, Toman J, Grosse Y (2017) Mycotoxins as human carcinogensāthe IARC monographs classification. Mycotoxin Res 33:65ā73. https://doi.org/10.1007/s12550-016-0265-7
Paik PK, Arcila ME, Fara M et al (2011) Clinical characteristics of patients with lung adenocarcinomas harboring BRAF mutations. J Clin Oncol 29(15):2046ā2051. https://doi.org/10.1200/JCO.2010.33.1280
Palumbo E (2007) Association between schistosomiasis and Cancer. Infect Dis Clin Pract 15:145ā148. https://doi.org/10.1097/01.idc.0000269904.90155.ce
Pane F, Intrieri M, Quintarelli C et al (2002) BCR/ABL genes and leukemic phenotype: from molecular mechanisms to clinical correlations. Oncogene 21:8652ā8667. https://doi.org/10.1038/sj.onc.1206094
Pasqualucci L, Dominguez-Sola D, Chiarenza A et al (2011) Inactivating mutations of acetyltransferase genes in B-cell lymphoma. Nature 471:189ā195. https://doi.org/10.1038/nature09730
Peng Y, Croce CM (2016) The role of microRNAs in human cancer. Signal Transduct Target Ther 1:15004
Pitt JI (2000) Toxigenic fungi and mycotoxins. Br Med Bull 56(1):184ā192
Polonara G, Alvaro L, Regnicolo L (2012) Tumor progression. In: Imaging gliomas after treatment. Springer Milan, Milano, pp 151ā156
Quiros RM, Ding HG, Gattuso P et al (2005) Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due toBRAF andp53 mutations. Cancer 103:2261ā2268. https://doi.org/10.1002/cncr.21073
Raab-Traub N (2002) EpsteināBarr virus in the pathogenesis of NPC. Semin Cancer Biol 12:431ā441. https://doi.org/10.1016/S1044579X0200086X
Rahman N, Scott RH (2007) Cancer genes associated with phenotypes in monoallelic and biallelic mutation carriers: new lessons from old players. Hum Mol Genet 16:R60āR66. https://doi.org/10.1093/hmg/ddm026
Rubin H (1994) Experimental control of neoplastic progression in cell populations: Fouldsā rules revisited. Proc Natl Acad Sci U S A 91:6619ā6623. https://doi.org/10.1073/pnas.91.14.6619
Ruddon RW (2010) Introduction to the molecular biology of cancer. Prog Mol Biol Transl Sci 95:1ā8
Samba-Louaka A, NougayrĆØde J-P, Watrin C et al (2009) The Enteropathogenic Escherichia coli effector Cif induces delayed apoptosis in epithelial cells. Infect Immun 77:5471ā5477. https://doi.org/10.1128/IAI.00860-09
Sanchis-Gomar F, Garcia-Gimenez JL, Perez-Quilis C et al (2012) Physical exercise as an epigenetic modulator: eustress, the āpositive stressā as an effector of gene expression. J Strength Cond Res 26(12):3469ā3472
Savage KI, Harkin DP (2015) BRCA1, a ācomplexā protein involved in the maintenance of genomic stability. FEBS J 282:630ā646. https://doi.org/10.1111/febs.13150
Sawan C, Herceg Z (2010) Histone modifications and cancer. Adv Genet 70:57ā85
Saxonov S, Berg P, Brutlag DL (2006) A genome-wide analysis of CpG dinucleotides in the human genome distinguishes two distinct classes of promoters. Proc Natl Acad Sci U S A 103:1412ā1417. https://doi.org/10.1073/pnas.0510310103
Schlenk RF, Dƶhner K, Krauter J et al (2008) Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia. N Engl J Med 358(18):1909ā1918. https://doi.org/10.1056/NEJMoa074306
Scholte LLS, Pascoal-Xavier MA, Nahum LA (2018) Helminths and cancers from the evolutionary perspective. Front Med 5:90. https://doi.org/10.3389/fmed.2018.00090
Schwartz GG (2002) Hypothesis: does ochratoxin A cause testicular cancer? Cancer Causes Control 13:91ā100. https://doi.org/10.1023/a:1013973715289
Seo JS, Ju YS, Lee WC et al (2012) The transcriptional landscape and mutational profile of lung adenocarcinoma. Genome Res 22:2109ā2119. https://doi.org/10.1101/gr.145144.112
Shanmugam MK, Arfuso F, Arumugam S et al (2018) Role of novel histone modifications in cancer. Oncotarget 9:11414ā11426. https://doi.org/10.18632/oncotarget.23356
Sharma S, Kelly TK, Jones PA (2010) Epigenetics in cancer. Carcinogenesis 31:27ā36. https://doi.org/10.1093/carcin/bgp220
Shuh M, Beilke M (2005) The human T-cell leukemia virus type 1 (HTLV-1): new insights into the clinical aspects and molecular pathogenesis of adult t-cell leukemia/lymphoma (ATLL) and tropical spastic paraparesis/HTLV-associated myelopathy (TSP/HAM). Microsc Res Tech 68:176ā196. https://doi.org/10.1002/jemt.20231
Smith AL, Robin TP, Ford HL (2012) Molecular pathways: targeting the TGF-Ī² pathway for cancer therapy. Clin Cancer Res 18:4514ā4521. https://doi.org/10.1158/1078-0432.CCR-11-3224
Sripa B, Bethony JM, Sithithaworn P et al (2011) Opisthorchiasis and Opisthorchis-associated cholangiocarcinoma in Thailand and Laos. Acta Trop 120(Suppl):S158āS168. https://doi.org/10.1016/j.actatropica.2010.07.006
Stratton MR, Campbell PJ, Futreal PA (2009) The cancer genome. Nature 458(7239):719ā724
Therkildsen C, Bergmann TK, Henrichsen-Schnack T et al (2014) The predictive value of KRAS, NRAS, BRAF, PIK3CA and PTEN for anti-EGFR treatment in metastatic colorectal cancer: a systematic review and meta-analysis. Acta Oncol (Madr) 53(7):852ā864
Tomizawa D, Kiyokawa N (2017) Acute lymphoblastic leukemia. In: Hematological disorders in children. Springer Singapore, Singapore, pp 33ā60
Tomlinson IPM, Lambros MBK, Roylance RR, Cleton-Jansen AM (2002) Loss of heterozygosity analysis: practically and conceptually flawed? Genes Chromosomes Cancer 34(4):349ā353
Travaglione S, Fabbri A, Fiorentini C (2008) The rho-activating CNF1 toxin from pathogenic E. coli: a risk factor for human cancer development? Infect Agent Cancer 3:4
Van Antwerp DJ, Martin SJ, Kafri T et al (1996) Suppression of TNF-alpha-induced apoptosis by NF-kappaB. Science 274(5288):787ā789
van Tong H, Brindley PJ, Meyer CG, Velavan TP (2017) Parasite infection, carcinogenesis and human malignancy. EBioMedicine 15:12ā23
Vancheri C (2016) Cancer. In: Idiopathic pulmonary fibrosis. European Respiratory Society, pp 151ā159
Vennervald BJ, Polman K (2009) Helminths and malignancy. Parasite Immunol 31:686ā696. https://doi.org/10.1111/j.1365-3024.2009.01163.x
Vincent TL, Gatenby RA (2008) An evolutionary model for initiation, promotion and progression in carcinogenesis. Int J Oncol 32(4):729ā737
Vogelmann R, Amieva MR (2007) The role of bacterial pathogens in cancer. Curr Opin Microbiol 10:76ā81. https://doi.org/10.1016/j.mib.2006.12.004
Vogelstein B, Papadopoulos N, Velculescu VE et al (2013) Cancer genome landscapes. Science 339:1546ā1558. https://doi.org/10.1126/science.1235122
Wang L-H, Wu C-F, Rajasekaran N, Shin YK (2018) Loss of tumor suppressor gene function in human cancer: an overview. Cell Physiol Biochem 51:2647ā2693. https://doi.org/10.1159/000495956
Weiss RA (2004) Multistage carcinogenesis. Br J Cancer 91:1981ā1982. https://doi.org/10.1038/sj.bjc.6602318
Wu S, Lim K-C, Huang J et al (1998) Bacteroides fragilis enterotoxin cleaves the zonula adherens protein, E-cadherin. Proc Natl Acad Sci U S A 95:14979ā14984. https://doi.org/10.1073/pnas.95.25.14979
Yanaihara N, Caplen N, Bowman E et al (2006) Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9(3):189ā198. https://doi.org/10.1016/j.ccr.2006.01.025
Yokota J (2000) Tumor progression and metastasis. Carcinogenesis 21:497ā503. https://doi.org/10.1093/carcin/21.3.497
Zanger P, Habscheid W, Kremsner PG, Dahm HH (2010) Schistosoma japonicum infection and rectal carcinoid tumour: underreported coincidence or neglected association? Epidemiol Infect 138:1289ā1291. https://doi.org/10.1017/S095026880999152X
Zarbl H, Sukumar S, Arthur AV et al (1985) Direct mutagenesis of Ha-ras-1 oncogenes by N-nitroso-N-methylurea during initiation of mammary carcinogenesis in rats. Nature 315:382ā385. https://doi.org/10.1038/315382a0
Zheng Z-M (2010) Viral oncogenes, noncoding RNAs, and RNA splicing in human tumor viruses. Int J Biol Sci 6(7):730ā755. https://doi.org/10.7150/ijbs.6.730
Acknowledgements
The authors wish to acknowledge(i) DST-FIST (Grant No. SR/FST/LSI-639/2015(C)), (ii) UGC-SAP (Grant No. F.5-1/2018/DRS-II (SAP-II)), (iii) DST-PURSE (Grant No. SR/PURSE Phase 2/38 (G)),Rc S.O. (P)/DST-PURSE Phase II/P1464/2019, (iv) RUSA 2.0 [F. 24-51/2014-U, Policy (TN Multi-Gen), and (v) Department of Education, Govt. of India] and the University Science Instrumentation Centre (USIC), Alagappa University.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
Ā© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Kiruthiga, C., Devi, K.P. (2021). Mechanisms Involved in Carcinogenesis. In: Jafari, S.M., Nabavi, S.M., Silva, A.S. (eds) Nutraceuticals and Cancer Signaling. Food Bioactive Ingredients. Springer, Cham. https://doi.org/10.1007/978-3-030-74035-1_2
Download citation
DOI: https://doi.org/10.1007/978-3-030-74035-1_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-74034-4
Online ISBN: 978-3-030-74035-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)